Newfeed

SAN FRANCISCO and SUZHOU, China, June 14, 2024 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, metabolic, oph

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: